Equities

Sanofi SA

0O59:LSE

Sanofi SA

  • Price (EUR)92.11
  • Today's Change1.57 / 1.73%
  • Shares traded50.04k
  • 1 Year change-7.22%
  • Beta--
Data delayed at least 20 minutes, as of May 13 2024 11:57 BST.
More ▼

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Sanofi SA's net income fell -35.49% from 8.37bn to 5.40bn despite relatively flat revenues. A contributing factor has been an increase in the percentage of sales devoted to the cost of goods sold from 30.17% to 30.65%.
Gross margin68.74%
Net profit margin10.14%
Operating margin14.69%
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in EURView more

In 2023, cash reserves at Sanofi SA fell by 4.03bn. However, the company earned 10.26bn from its operations for a Cash Flow Margin of 22.09%. In addition the company used 6.20bn on investing activities and also paid 8.05bn in financing cash flows.
Cash flow per share5.57
Price/Cash flow per share17.11
Book value per share--
Tangible book value per share--
More ▼

Balance sheet in EURView more

Sanofi SA uses little or no debt in its capital structure.
Current ratio--
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼

Growth rates in EUR

SmartText is unavailable
Div yield(5 year avg)3.89%
Div growth rate (5 year)4.14%
Payout ratio (TTM)103.68%
EPS growth(5 years)4.55
EPS (TTM) vs
TTM 1 year ago		-45.69
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.